Fidelity Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-467,573
| Closed | -$31.8M | – | 5702 |
|
|
2022
Q3 | $31.8M | Sell |
467,573
-2,614,144
| -85% | -$144M | ﹤0.01% | 1430 |
|
|
2022
Q2 | $98.5M | Sell |
3,081,717
-1,009,982
| -25% | -$29.6M | 0.01% | 979 |
|
|
2022
Q1 | $142M | Sell |
4,091,699
-190,702
| -4% | -$5.7M | 0.01% | 923 |
|
|
2021
Q4 | $125M | Buy |
4,282,401
+1,276,350
| +42% | +$39.5M | 0.01% | 1007 |
|
|
2021
Q3 | $76.6M | Buy |
3,006,051
+1,561,094
| +108% | +$45.9M | 0.01% | 1224 |
|
|
2021
Q2 | $50.6M | Sell |
1,444,957
-1,466,007
| -50% | -$57.2M | ﹤0.01% | 1423 |
|
|
2021
Q1 | $119M | Sell |
2,910,964
-1,496,101
| -34% | -$68.8M | 0.01% | 997 |
|
|
2020
Q4 | $191M | Sell |
4,407,065
-2,253,143
| -34% | -$111M | 0.02% | 762 |
|
|
2020
Q3 | $367M | Sell |
6,660,208
-2,480,246
| -27% | -$158M | 0.04% | 411 |
|
|
2020
Q2 | $577M | Buy |
9,140,454
+772,248
| +9% | +$53M | 0.06% | 276 |
|
|
2020
Q1 | $428M | Buy |
8,368,206
+3,131,851
| +60% | +$210M | 0.06% | 285 |
|
|
2019
Q4 | $416M | Sell |
5,236,355
-855,714
| -14% | -$50.7M | 0.05% | 380 |
|
|
2019
Q3 | $296M | Sell |
6,092,069
-1,832,916
| -23% | -$95.5M | 0.04% | 475 |
|
|
2019
Q2 | $417M | Sell |
7,924,985
-492,724
| -6% | -$28.3M | 0.05% | 378 |
|
|
2019
Q1 | $446M | Buy |
8,417,709
+88,310
| +1% | +$4.34M | 0.05% | 343 |
|
|
2018
Q4 | $342M | Buy |
8,329,399
+521,563
| +7% | +$19.5M | 0.05% | 391 |
|
|
2018
Q3 | $297M | Buy |
7,807,836
+1,357,642
| +21% | +$60.1M | 0.03% | 516 |
|
|
2018
Q2 | $292M | Sell |
6,450,194
-767,345
| -11% | -$34.9M | 0.03% | 508 |
|
|
2018
Q1 | $349M | Buy |
7,217,539
+1,633,486
| +29% | +$91.1M | 0.04% | 464 |
|
|
2017
Q4 | $220M | Buy |
5,584,053
+357,122
| +7% | +$13.3M | 0.03% | 650 |
|
|
2017
Q3 | $162M | Sell |
5,226,931
-164,719
| -3% | -$4.63M | 0.02% | 766 |
|
|
2017
Q2 | $147M | Sell |
5,391,650
-367,821
| -6% | -$10.9M | 0.02% | 804 |
|
|
2017
Q1 | $212M | Buy |
5,759,471
+162,004
| +3% | +$4.08M | 0.03% | 668 |
|
|
2016
Q4 | $80.9M | Buy |
5,597,467
+4,656
| +0.1% | +$81.8K | 0.01% | 1100 |
|
|
2016
Q3 | $129M | Buy |
5,592,811
+59,350
| +1% | +$1.13M | 0.02% | 859 |
|
|
2016
Q2 | $91.8M | Buy |
5,533,461
+959,169
| +21% | +$19.4M | 0.01% | 1018 |
|
|
2016
Q1 | $72.5M | Buy |
4,574,292
+5,730
| +0.1% | +$102K | 0.01% | 1107 |
|
|
2015
Q4 | $148M | Buy |
4,568,562
+154,129
| +3% | +$6.67M | 0.02% | 794 |
|
|
2015
Q3 | $186M | Buy |
+4,414,433
| New | +$208M | 0.03% | 664 |
|
Other funds holding GBT
Fidelity Investments's GBT Position: Q4 2022 in Review
Fidelity Investments sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 467,573 shares — an estimated $31.8M sold.
Fidelity Investments first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $577M in Q2 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Fidelity Investments reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Fidelity Investments sold 467,573 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $31.8M.
- Fidelity Investments first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
- Fidelity Investments's Global Blood Therapeutics, Inc. position peaked at $577M in Q2 2020.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Fidelity Investments's 13F filing for Q4 2022, filed 13 Feb 2023.